Max Gill

VP, Market Access

Max Gill has more than 20 years of health economic, health policy, and reimbursement experience in the medical device industry. Before joining Beta Bionics, Mr. Gill led Health Economics & Reimbursement teams at Medtronic Diabetes, Covidien (Surgical Division), and Cyberonics. Prior to that, he spent six years working at Blue Cross Blue Shield in Kansas City.  At Beta Bionics, Mr. Gill is a subject matter expert in market access and reimbursement who provides strategic insight and planning aimed at ensuring rapid and comprehensive access for the launch of the Company’s first product following FDA clearance. He holds an MBA degree and a BA degree in management from Southeastern Louisiana University, as well as a Bachelor of Commerce degree in cost accounting from Punjab University in India.

What drew you to work in the diabetes industry?





Why did you choose to work at Beta Bionics?





What is the most rewarding part about working at Beta Bionics?






CAUTION: The iLet® bionic pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale.

© 2021 Beta Bionics, Inc. Beta Bionics® and iLet® are registered trademarks of Beta Bionics, Inc. All rights reserved. All other trademarks are the property of their respective owners. The use of third-party trademarks does not constitute an endorsement or imply a relationship or other affiliation.